CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage.

Manuel Navarro-Oviedo Juan Marta-Enguita Carmen Roncal Jose Antonio RodríguezBeatriz ZandioRamón LecumberriJose Hermida Julen OyarzábalAntonio Pineda-LucenaJose Antonio Paramo Roberto Muñoz Josune Orbe

Published in: Thrombosis and haemostasis (2022)

CM-352 treatment, by diminishing MMPs and rivaroxaban-associated fibrinolytic effects, might be a novel antihemorrhagic strategy for rivaroxaban-associated ICH.

Keyphrases

venous thromboembolism
atrial fibrillation
mouse model
pulmonary embolism
combination therapy
smoking cessation
optic nerve